Hudson Bay Capital Management LP 13D/13G Filings for InMed Pharmaceuticals Inc. (INM)

Hudson Bay Capital Management LP 13D and 13G filings for InMed Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-04
3:29 pm
Purchase
2021-12-31 13G InMed Pharmaceuticals Inc.
INM
Hudson Bay Capital Management LP 56
3.810%
12increase
(+25.99%)
Filing
2021-02-09
4:05 pm
Purchase
2020-12-31 13G InMed Pharmaceuticals Inc.
INM
Hudson Bay Capital Management LP 44
5.970%
44increase
(New Position)
Filing